Ostrum Asset Management’s ResMed RMD Stock Holding History

Ostrum Asset Management’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$529K	Buy	2,716 +1,627	+149%	+$337K	0.03%	319
2026 Q1	$244K	Sell	1,089 -1,707	-61%	-$425K	0.01%	490
2025 Q4	$673K	Sell	2,796 -928	-25%	-$237K	0.03%	339
2025 Q3	$1.02M	Buy	3,724 +1,807	+94%	+$494K	0.05%	308
2025 Q2	$495K	Sell	1,917 -4,267	-69%	-$1.02M	0.02%	409
2025 Q1	$1.38M	Buy	6,184 +4,984	+415%	+$1.16M	0.07%	244
2024 Q4	$274K	Sell	1,200 -51	-4%	-$12.3K	0.02%	469
2024 Q3	$305K	Sell	1,251 -1,963	-61%	-$439K	0.03%	451
2024 Q2	$615K	Sell	3,214 -4,262	-57%	-$865K	0.05%	365
2024 Q1	$1.48M	Hold	7,476	–	–	0.12%	275
2023 Q4	$1.29M	Sell	7,476 -1,300	-15%	-$200K	0.11%	263
2023 Q3	$1.3M	Sell	8,776 -1,579	-15%	-$286K	0.12%	257
2023 Q2	$2.26M	Buy	10,355 +9	+0.1%	+$2.01K	0.19%	182
2023 Q1	$2.27M	Buy	+10,346	New	+$2.24M	0.2%	182

Other funds holding RMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Ostrum Asset Management's RMD Position: Q2 2026 in Review

Ostrum Asset Management increased its ResMed (RMD) stake by 149% in Q2 2026, buying an estimated $337K and bringing the position to 2,716 shares worth $529K. The position accounts for 0.03% of the portfolio, ranked #319.

Ostrum Asset Management first reported a position in RMD in Q1 2023 and has held it in 14 quarters since. The position peaked at $2.27M in Q1 2023. 887 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

Ostrum Asset Management held 2,716 shares of ResMed worth $529K as of Q2 2026.
Ostrum Asset Management bought 1,627 ResMed shares in Q2 2026, an estimated $337K.
ResMed made up 0.03% of Ostrum Asset Management's portfolio in Q2 2026, its #319 holding.
Ostrum Asset Management first reported a position in ResMed in Q1 2023 and has held it in 14 quarters since.
Ostrum Asset Management's ResMed position peaked at $2.27M in Q1 2023.
887 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Ostrum Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.